One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Adverse effects of plaquenil menstrual cycle Chloroquine resistant area cdc Rogaine for plaquenil hair loss What is the chemical name for plaquenil Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Hydroxychloroquine and hearing loss Introduction Hydroxychloroquine Plaquenil® is an antimalarial agent which is approved for rheumatoid arthritis, systemic lupus erythematosis, discoid lupus erythematosis, prophylaxis and treatment of acute malaria, and photodermatosis 1. In the Netherlands it has been approved since 1966. Plaquenil has been a life-saving drug for me, quite literally. I was a mess in 2004-2005 and then a dr put me on Plaquenil, and in 3 weeks most of my symptoms had disappeared. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil ototoxicity Plaquenil - FDA prescribing information, side effects and uses, Hydroxychloroquine and hearing loss - Lareb Hydroxychloroquine elimination It should be noted that 4-aminoquinolines in therapeutic doses have been associated with central nervous system damage, including ototoxicity auditory and vestibular toxicity, congenital deafness, retinal hemorrhages and abnormal retinal pigmentation. Therefore Plaquenil should not be used in pregnancy. Lactation Plaquenil 200mg Film-coated Tablets - Summary of Product.. Hydroxychloroquine Reviews Everyday Health. Multimodal Imaging in Plaquenil Toxicity. PLATINOL cisplatin for injection, USP should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Ototoxicity, which may be more pronounced in children, and is manifested by tinnitus, and/or loss of high frequency hearing and occasionally deafness, is significant. Note This document contains side effect information about hydroxychloroquine. Some of the dosage forms listed on this page may not apply to the brand name Plaquenil. For the Consumer. Applies to hydroxychloroquine oral tablet. Along with its needed effects, hydroxychloroquine the active ingredient contained in Plaquenil may cause some unwanted effects. Less-common reactions to Plaquenil therapy include leukopenia, thrombocytopenia, and ototoxicity. Tell your patient to notify her health care provider if she has fever, chills, sore throat, unusual bleeding or bruising, ringing in her ears, or changes in hearing.